MIRA Stock Summary and Trading Ideas (Mira Pharmaceuticals | NASDAQ:MIRA)

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Mira Pharmaceuticals trades on the NASDAQ stock market under the symbol MIRA.

As of April 28, 2026, MIRA stock price declined to $1.01 with 206,881 million shares trading.

MIRA has a beta of 2.04, meaning it tends to be more sensitive to market movements. MIRA has a correlation of 0.13 to the broad based SPY ETF.

MIRA has a market cap of $42.29 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that MIRA belongs to (by Net Assets): VXF, VTI.

MIRA has underperformed the market in the last year with a price return of -2.9% while the SPY ETF gained +30.6%. MIRA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.6% and -1.9%, respectively, while the SPY returned +2.6% and +3.7%, respectively.

MIRA support price is $.97 and resistance is $1.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIRA shares will trade within this expected range on the day.